FluidForm’s FRESH technologies may offer a solution to 3D printing challenging materials such as collagen and silicone.
by Jeffrey Heimgartner – engineering.com
Limited organ donors, medical materials unable to support human tissue growth, and costly drug testing failures are all challenges that researchers face in the medical field. 3D printing is steadily becoming an alternative for making progress in these areas but still has its limitations, especially when it comes to engineering human tissue.
FluidForm, a Massachusetts-based regenerative medicine company, aims to take on those challenges with its liquid 3D printing technology.
